June 24, 2021

Antibody Production Market Size & Share 2021 | Global Growth Segments, Emerging Trends and Business Strategy with Opportunities and Insights of top Players till 2024

Antibody Production

Antibody Production Market” report helps to gain a deeper insight of the market overall landscape with qualitative and quantitative aspects of various industry factors like growth, size and share. The report consists of an extensive primary research associated with rapidly changing dynamics and current scenario of Antibody Production industry with latest developments. Antibody Production market also shows information of Product awareness, adept workforce, technological advancements, raw material affluence, favorable environment.

Get a Sample Copy of the Report – https://www.industryresearch.co/enquiry/request-sample/14245672

Scope of the Report:

As per the , antibody production refers to the process of creating a specific antibody. In a broad sense, it consists of various methods, such as upstream, downstream, and filtration. The process involves the preparation of antigen samples, which are injected to the laboratory or farm animals to evoke high expression levels of antigen-specific antibodies in the serum, which are then recovered from the animal. The market is expected to witness significant growth, owing to the increase in R&D expenditure of pharmaceutical and biotechnology companies.

Major Key Players:

  • Applikon Biotechnology Inc.
  • Cellab GmbH
  • Danaher Corporation
  • Eppendorf AG
  • GE Healthcare
  • Genetix Biotech Asia Pvt Ltd
  • Merck KGaA
  • Sartorius AG
  • Solaris Biotech
  • Thermo Fisher Scientific Inc.

    Market Overview:

  • The major factors for the growth of the antibody production market include the rising adoption of targeted immunotherapy, the increase in the R&D expenditure of pharmaceutical and biotechnology companies, and the rising demand for therapeutic antibodies.
  • Antibodies are used in the treatment of various diseases, such as cancer, rheumatoid arthritis, and other chronic diseases. The targeted therapy is attaining importance due to its specificity toward cancer cells while sparing the toxicity to off-target cells. As there is a rising prevalence of cancer, targeted therapies are getting more attention. For instance, according to the estimates of the American Cancer Society, in 2018, there were 1,735,350 new cancer cases diagnosed and 609,640 deaths, due to cancer, in the United States. Some of the examples of monoclonal antibodies used in targeted therapies are bevacizumab, cetuximab, and ipilimumab.
  • The rising adoption of targeted therapies is expected to propel the overall growth of the antibody production market over the forecast period. Furthermore, there is an increase in R&D activities by most of the pharmaceutical and biotechnology companies, in order to develop advanced biologics. The success rates and blockbuster sales of biologics have also made large pharmaceutical companies shift their presence to biopharma. Over the past two decades, the chimerization and humanization of mAbs (monoclonal antibodies) have led to the approval of several for the treatment of autoimmune diseases, cancer, and transplant rejection.
  • However, the costs of antibody production and stringent government regulations are expected to impede the growth of the market.

    For More Information or Query or Customization Before Buying, Visit at – https://www.industryresearch.co/enquiry/pre-order-enquiry/14245672

    Our Research Report Includes:

    • Antibody Production Market size & share analysis
    • Top market players along with sales, revenue, and business strategies analysis
    • Antibody Production Market growth drivers and restraints
    • Market opportunities & challenges
    • Research methodology and impact of Covid-19 on Industry

    Key Market Trends:

    The Monoclonal Antibodies Segment under the Antibody Type Accounted for the Largest Share in the Global Market

    Monoclonal antibodies have large applications in the field of diagnostics, therapeutics, and targeted drug delivery systems, not only for infectious diseases caused by bacteria, viruses, and protozoa, but also for cancer, metabolic, and hormonal disorders. This segment is expected to account for the largest market share during the forecast period, owing to the rising investment in monoclonal antibody research and an increase in antibody-based product launches. Furthermore, there is a growing collaboration between pharma companies to develop advanced monoclonal antibodies. For instance, recently, in September 2018, Integral Molecular and Merus NV announced that they have entered into a collaboration on multiple undisclosed targets, as Integral Molecular is one of the leaders in membrane protein antibody discovery. The partnership is expected to increase the R&D capabilities of Merus NV.

    The polyclonal antibody segment is expected to be the fastest-growing market, owing to benefits, such as ease of production, low price, and diagnosis of diseases with high proficiency.

    North America Accounted for the Largest Share in the Global Market

    North America is found to hold a significant share in the antibody production market and is expected to show a similar trend over the forecast period, without substantial fluctuations. The presence of favorable healthcare infrastructure and the rising prevalence of various chronic diseases are the major factors driving the growth of the market. Furthermore, there is a rise in the approval of monoclonal antibodies for the treatment of cancer and various types of diseases, which is one of the major factors contributing to the high growth of the market in North America. For instance, in May 2018, Novartis announced that the US FDA approved Kymriah (tisagenlecleucel) suspension for the treatment of adult patients with relapsed or refractory large B-cell lymphoma.

    Competitive Landscape:

    Most of the companies present in the market are efficient at the technological front, but require significant support for enhancing their services and expanding their businesses. Thus, mergers and acquisitions offer significant opportunities to gain the attention of a large number of providers across developed regions.

    Purchase this Report (Price 4250 USD for single user license) – https://www.industryresearch.co/purchase/14245672

    Detailed TOC of Antibody Production Market Report 2024:

    1 INTRODUCTION
    1.1 Study Deliverables
    1.2 Study Assumptions
    1.3 Scope of the Study

    2 RESEARCH METHODOLOGY

    3 EXECUTIVE SUMMARY

    4 MARKET DYNAMICS
    4.1 Market Overview
    4.2 Market Drivers
    4.2.1 Rising Adoption of Targeted Immunotherapy
    4.2.2 Increase in the R&D Expenditure of Pharmaceutical and Biotechnology Companies
    4.2.3 Rising Demand for Therapeutic Antibodies
    4.3 Market Restraints
    4.3.1 High Costs Involved in the Antibody Production
    4.3.2 Stringent Government Regulations
    4.4 Porter’s Five Forces Analysis
    4.4.1 Threat of New Entrants
    4.4.2 Bargaining Power of Buyers/Consumers
    4.4.3 Bargaining Power of Suppliers
    4.4.4 Threat of Substitute Products
    4.4.5 Intensity of Competitive Rivalry

    5 MARKET SEGMENTATION
    5.1 Antibody Type
    5.1.1 Monoclonal Antibodies
    5.1.2 Polyclonal Antibodies
    5.1.3 Other Antibody Types
    5.2 Process
    5.2.1 Upstream Processing
    5.2.1.1 Bioreactors
    5.2.1.2 Consumables
    5.2.2 Downstream Processing
    5.2.2.1 Chromatography Systems
    5.2.2.2 Chromatography Resins
    5.2.3 Filtration
    5.3 End User
    5.3.1 Pharmaceutical and Biotechnology Companies
    5.3.2 Research Laboratories
    5.3.3 Other End Users
    5.4 Geography
    5.4.1 North America
    5.4.1.1 US
    5.4.1.2 Canada
    5.4.1.3 Mexico
    5.4.2 Europe
    5.4.2.1 Germany
    5.4.2.2 UK
    5.4.2.3 France
    5.4.2.4 Italy
    5.4.2.5 Spain
    5.4.2.6 Rest of Europe
    5.4.3 Asia-Pacific
    5.4.3.1 China
    5.4.3.2 Japan
    5.4.3.3 India
    5.4.3.4 Australia
    5.4.3.5 South Korea
    5.4.3.6 Rest of Asia-Pacific
    5.4.4 Middle East & Africa
    5.4.4.1 GCC
    5.4.4.2 South Africa
    5.4.4.3 Rest of Middle East & Africa
    5.4.5 South America
    5.4.5.1 Brazil
    5.4.5.2 Argentina
    5.4.5.3 Rest of South America

    6 COMPETITIVE LANDSCAPE
    6.1 Company Profiles
    6.1.1 Applikon Biotechnology Inc.
    6.1.2 Cellab GmbH
    6.1.3 Danaher Corporation
    6.1.4 Eppendorf AG
    6.1.5 GE Healthcare
    6.1.6 Genetix Biotech Asia Pvt Ltd
    6.1.7 Merck KGaA
    6.1.8 Sartorius AG
    6.1.9 Solaris Biotech
    6.1.10 Thermo Fisher Scientific Inc.

    7 MARKET OPPORTUNITIES AND FUTURE TRENDS

    Contact Us:

    Name: Ajay More

    Phone: US +14242530807/ UK +44 20 3239 8187

    Email: [email protected]

    Our Other Reports:

    Probiotics Market Size and Forecast 2021 to 2024: By Global Industry Share, Key Leading Countries, Geographic Segmentation, Opportunity by Applications with Covid-19 Impact

    Mechanical Vapor Recompression (MVR) Compressor Market Growth Opportunities, Size Outlook 2021: Business Prospect and Industry Share, Competition Strategies, Revenue Analysis Forecast to 2026 | Industry Research.co

    SMD Thick Film Resistors Market Size and Growth Analysis by Regions 2021: Global Business Strategies Developed by Leading Players, Latest Trends and Technologies Forecast to 2026

    Custodial Data Aggregation Market Size Forecast Analysis 2021 to 2025 | Growth Factors by Regions, Key Market Findings and Future Prospects, and Demand Status Analysis

    Corrosion Resistant Alloys Market Share 2021 by Key Findings, Emerging Growth Factors, Driving Factors by Manufacturers, Key Strategies of Business, Global Size Value Forecast to 2024 Report by Industry Research.co

    1,5-pentanediamine (Cadaverine) Market Size, Share and Competitive Analysis 2021 Top Countries by Regions, Industry Revenue, Gross Margin, Business Overview, and Recent Developments till 2026

    Global N Sunscreen Cream Market Size Outlook by Future Opportunity 2021 | Global Survey, Demand Status, Business Trends, Major Drivers, Covid-19 Impact Analysis on Industry Share Forecast by 2025

    Welding Gases Market Size and Growth Drivers 2021 | Industry Share, Emerging Trends by Future Demand, Competitive Landscape, and Growing Opportunities with Covid-19 Impact Forecast to 2026

    Smart Pills Market Research Report 2021 | Share by Company Profiles, Growth Drivers, Global Industry Size, Covid-19 Impact Analysis with Future Scope, and Revenue Forecast to 2027

    Medical Emergency Ventilator Market Growth Analysis, Recent Developments of Top Key Players, Research Findings, Business Size and Share Insights, Consumption and Demand Forecast to 2021-2027 with Impact of Covid-19

    Explosive Vapour Detector Market Size – COVID-19 Impact on Industry Growth 2021, Demand Status, New Technology, and Share Analysis with Business Opportunities Forecast to 2025

    Global Pavement Construction Machinery Market Trends by Business Prospects 2021: Future Scope with Top Players, Global Opportunities, Share Analysis and Business Growth Size Forecast to 2027

    https://glendivegazette.com/